1-9 of 9
Carole S. Paley, MD
Close
Sort by
Journal Articles

Time To Event Analyses in PANORAMA 2: A Phase 2 Study Of Panobinostat, Bortezomib, and Dexamethasone In Patients With Relapsed and Bortezomib-Refractory Multiple Myeloma

Paul G. Richardson, MD, Robert L. Schlossman, MD, Melissa Alsina, MD, Donna M. Weber, M.D., Steven E. Coutre, MD, Cristina Gasparetto, MD, Sutapa Mukhopadhyay, PhD, Michael S. Ondovik, PharmD, MBA, Mahmudul Khan, PhD, Carole S. Paley, MD, Sagar Lonial, M.D.
Journal: Blood
Blood (2013) 122 (21): 1970.
https://doi.org/10.1182/blood.V122.21.1970.1970
Published: 2013
Journal Articles

48-Month Update On Survival and AML Transformation In a 600-Patient Registry Of Lower-Risk MDS Patients

Roger M. Lyons, MD, Billie J. Marek, MD, Carole S. Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2013) 122 (21): 2775.
https://doi.org/10.1182/blood.V122.21.2775.2775
Published: 2013
Journal Articles

Transition From Pediatric To Adult Care Of High Cost Patients In a Medicaid Population With Sickle Cell Disease

Morey A. Blinder, MD, Medha Sasane, BPharm, PhD, Jonathan Fortier, MA, Carole S. Paley, MD, Mei S. Duh, ScD, MPH, Francis Vekeman, MA
Journal: Blood
Blood (2013) 122 (21): 2927.
https://doi.org/10.1182/blood.V122.21.2927.2927
Published: 2013
Journal Articles

Age-Related Iron Chelation Utilization and Healthcare Costs in Patients with Sickle Cell Disease (SCD)

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2011) 118 (21): 338.
https://doi.org/10.1182/blood.V118.21.338.338
Published: 2011
Journal Articles

Age-Related Blood Transfusion Patterns in Patients with Sickle Cell Disease (SCD) and the Association with Sickle Cell Complications

Morey A. Blinder, MD, Francis Vekeman, MA, Alex Trahey, BA, Medha Sasane, PhD, Carole S. Paley, MD, Mei Sheng Duh, MPH, ScD
Journal: Blood
Blood (2011) 118 (21): 12.
https://doi.org/10.1182/blood.V118.21.12.12
Published: 2011
Journal Articles

A Phase II Trial of Panobinostat, an Orally Available Deacetylase Inhibitor (DACi), in Patients with Primary Myelofibrosis (PMF), Post Essential Thrombocythemia (ET), and Post Polycythemia Vera (PV) Myelofibrosis

Daniel J DeAngelo, MD, PhD, Ayalew Tefferi, MD, Warren Fiskus, PhD, Ruben A. Mesa, MD, Carole S. Paley, MD, Martha Wadleigh, MD, David S. Snyder, MD, Kebede Begna, MD, Michael S. Ondovik, Jessica Rine, Kapil N. Bhalla, MD
Journal: Blood
Blood (2010) 116 (21): 630.
https://doi.org/10.1182/blood.V116.21.630.630
Published: 2010
Journal Articles

Strategies to Improve Iron Chelation In Thalassemia Patients Poorly Responsive to Deferasirox:

Deborah Chirnomas, MD, MPH, Aleksandra Yakhkind, MS, Carole S. Paley, MD, Ellis J. Neufeld, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4279.
https://doi.org/10.1182/blood.V116.21.4279.4279
Published: 2010
Journal Articles

The Palatability and Tolerability of Deferasirox (Exjade®) Taken with Meals, Different Liquids, or Crushed and Added to Food

Stuart L Goldberg, MD, Patricia Giardina, MD, Joan Parkhurst Cain, MD, Deborah Chirnomas, MD, MPH, Jason Esposito, Carole S. Paley, MD, Elliott Vichinsky, MD
Journal: Blood
Blood (2010) 116 (21): 5155.
https://doi.org/10.1182/blood.V116.21.5155.5155
Published: 2010
Journal Articles

Optimizing the Use of Deferasirox: Evidence of Synergy When Combined with Deferoxamine

Robert W Grady, PhD, Renzo Galanello, MD, Dorothy A Kleinert, NP, MPH, Carole S. Paley, MD, Patricia J. Giardina, MD
Journal: Blood
Blood (2010) 116 (21): 5163.
https://doi.org/10.1182/blood.V116.21.5163.5163
Published: 2010